The Efficacy and Safety of Nirmatrelvir/Ritonavir Against COVID-19 in Elderly Patients.

Authors:
Xiang Z; Wang Y; Qu Y; Lv B; Han J and 4 more

Journal:
Int J Gen Med

Publication Year: 2024

DOI:
10.2147/IJGM.S446335

PMCID:
PMC10838049

PMID:
38314196

View on PubMed View on PMC View Publisher

Journal Information

Full Title: Int J Gen Med

Abbreviation: Int J Gen Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, General & Internal

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal

View All Papers from This Journal

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Disclosure The authors report no conflicts of interest in this work."

Funding Disclosure

Evidence found in paper:

"This work is supported by the National Natural Science Foundation of China (No. 82102486), Gusu Talent Program (GSWS2021022), and Jiangsu Research Hospital Association for Precision Medication (JY202032)."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025